EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Metagenomi Therapeutics, Inc. (MGX) on Tuesday reported a loss of $21.1 million in its third quarter. On a per-share basis, the Emeryville, California-based company said it had a loss of 56 cents. The genetic medicines company posted revenue of $2.2 million in the period. _____ This story...